i2e Elevate returned for its second edition on April 24, 2026, in New York, bringing together senior R&D portfolio leaders for a focused forum of peer discussions, practical insights, and expert led dialogue.The forum explored the future of pharma portfolio maturity, clinical trial excellence, and the growing role of AI in enabling more connected decision making across life sciences.
i2e was a gold partner at the Why Summits 2025, Mumbai edition, where we had the opportunity to connect with pharma leaders, exchange insights, and explore strategies for optimizing portfolio management. Our expert session on rethinking SPM maturity in pharma showcased how APEx can drive value in fast-scaling pharmaceutical portfolios.
Elevate 2025 gathered a small, invite-only group of senior R&D and portfolio leaders in NYC to shape the future of pharma R&D decision making. From expert perspectives to candid hallway conversations, the forum started meaningful dialogues to advance prioritization, resource allocation, governance, AI’s role in portfolio intelligence, and more.
Our SMEs exhibited at booth #228, at the SCDM annual conference 2025 in Baltimore. We interacted with leaders who want more control and less complexities, and teams who simply want tools to ‘talk to each other’ and help them focus on value-driving strategic initiatives. Our hands-on API game also helped demonstrate how system integrations resolve issues in real-time, while eliminating manual work.
NYC
